Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesHematocrit and risk of venous thromboembolism in a general population. The Tromso Study
Haematologica, 10/21/09
Braekkan SK et al. – Hematocrit above the normal population range, such as in primary or secondary erythrocytosis, predisposes to both arterial and venous thrombosis. However, less is known about the association between hematocrit and risk of venous thromboembolism (VTE) in a general population. The findings suggest that hematocrit and related hematological variables such as hemoglobin and RBC–c represent risk factors of VTE in a general population.
Related Articles
Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
Chest, 10/08/09
Relevance Score: 83%
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
Circulation, 11/04/09
Relevance Score: 82%
2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
Critical Reviews in Oncology/Hematology, 10/07/09
Relevance Score: 82%
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Annals of Oncology, 10/20/09
Relevance Score: 81%
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Cochrane Reviews, 10/09/09
Relevance Score: 81%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
Transfusion, 12/19/09
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis
Transfusion, 12/19/09
Particulate Air Pollution and Cardiovascular Risk: Short-term and Long-term Effects
Seminars in Thrombosis and Hemostasis, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor